<DOC>
	<DOCNO>NCT00352599</DOCNO>
	<brief_summary>Neurofibromatosis type I ( NF1 ) genetic disorder affect approximately 1 3500 individual . Half people NF1 inherit condition parent , half new occurrence condition . The manifestation NF1 highly variable multiple organ system typically affect . Some common symptom include benign neurofibroma , caf√© au lait spot , Lisch nodule ( tan spot iris eye ) . Some individual NF1 also exhibit severe associate condition , optic pathway tumor ( glioma ) bone bend curve . Neurocognitive deficit specific learn disability occur approximately 30 50 % individual NF1 regard observer sufferer among trouble feature disease . The commonly report finding deficit visuoperceptual ability , motor coordination , expressive receptive language , executive functioning , require intact short-term memory attention . Patients NF1 also show slight depression mean IQ score compare healthy adult without disorder . While cognitive deficit widely-recognized feature Neurofibromatosis Type 1 ( NF1 ) , precise cause deficit still remain determined . Dr. Alcino Silva , co- investigator study , develop animal model NF1 mouse specific mutation *NF1* gene . These mouse physically normal show specific learn impairment . Dr. Silva 's lab find treatment medication call lovastatin , drug typically use high cholesterol , reverse spatial deficit see animal . Lovastatin medication commonly use treat high cholesterol proven relatively safe tolerable human . The investigator conduct randomized , double-blinded , placebo- control , trial lovastatin patient NF1 . Participants randomly assign lovastatin placebo treat approximately 14 week baseline follow-up assessment evaluate safety effect neurocognitive test performance .</brief_summary>
	<brief_title>Trial Evaluate Safety Lovastatin Individuals With Neurofibromatosis Type I ( NF1 )</brief_title>
	<detailed_description />
	<mesh_term>Neurofibromatoses</mesh_term>
	<mesh_term>Neurofibroma</mesh_term>
	<mesh_term>Neurofibromatosis 1</mesh_term>
	<mesh_term>Lovastatin</mesh_term>
	<mesh_term>L 647318</mesh_term>
	<mesh_term>Dihydromevinolin</mesh_term>
	<criteria>1. diagnosis NF1 NIH criteria 2. 10 50 year age 3. evidence comorbid neurological disorder ( e.g. , epilepsy , encephalitis ) 4. currently take statin medication 5. suffer hypercholesterolemia base selfreport , collateral information physician , initial medical workup use National Cholesterol Education Program ( NCEP , JAMA 2001 ) , guideline accept American College Cardiology ( ACC ) American Heart Association ( AHA ) 6. aforementioned condition contraindicates use statin medication ( pregnancy , lactation , liver disease , use medication recommend use conjunction lovastatin ) . A negative pregnancy test require patient female reproductive year . 7. mentally retardation ( i.e. , IQ great 70 ) 8. evidence significant habitual alcohol drug abuse dependence 9. sufficient acculturation fluency English language avoid invalidate research measure think , language , speech disorder , verbal ability . 10. life Southern California area ( arrange ~5 visit Los Angeles 14 week ) 1. comorbid neurological condition 2. significant drug alcohol abuse 3. nonfluency English</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Neurofibromatosis Type 1</keyword>
	<keyword>NF1</keyword>
	<keyword>Lovastatin</keyword>
	<keyword>statin</keyword>
</DOC>